financetom
Business
financetom
/
Business
/
Update: New Gold Consolidates Free Cash Flow Interest from its New Afton Mine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: New Gold Consolidates Free Cash Flow Interest from its New Afton Mine
Apr 7, 2025 8:24 AM

11:09 AM EDT, 04/07/2025 (MT Newswires) -- (Adds comment and updates shares.

New Gold ( NGD ) said Monday it agreed to pay $300 million to consolidate free cash flow interest in the New Afton mine in British Columbia.

The company said it signed an agreement with Ontario Teachers' Pension Plan to acquire the remaining 19.9% free cash flow interest in the mine that it does not already own.

"This transaction allows us to grow in an exceptional location with no diligence or integration risk, and with no equity dilution to our shareholders," said chief executive Patrick Godin.

New Gold ( NGD ) said it plans to fund the cash payment with cash on hand, borrowings from its existing revolving credit facility and a gold prepayment financing.

For 2025, New Gold ( NGD ) said it is committing $17 million towards exploration, focusing on the mine's K-Zone.

"Our goal is to maximize this free cash flow generation at the mine, while continuing our exploration program to extend mine life and create further value for our shareholders and stakeholders," Godin said.

The transaction is expected to close in early May.

National Bank of Canada maintained its outperform rating and $6.50 price target following New Gold's ( NGD ) decision.

According to New Gold ( NGD ), the transaction may hinder the company's ability to pursue further M&A transactions in the very near term. Although it is likely to improve the company's free cash flow generation and future balance sheet strength.

"We continue to believe NGD will look for a third producing asset to add to its portfolio to aid production growth which we expect to peak in 2026," the bank said.

New Gold ( NGD ) shares were last seen up $0.12 to $4.39 on the Toronto Stock Exchange.

Price: 4.42, Change: +0.15, Percent Change: +3.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gemini Stock Jumps 45% in Early Trades After IPO
Gemini Stock Jumps 45% in Early Trades After IPO
Sep 12, 2025
Shares of Gemini (GEMI) opened at $41 a share on the Nasdaq Global Select Market on Friday, rising 45% from last night's IPO price. The crypto exchange, which is run by Tyler and Cameron Winklevoss, priced its IPO at $28 a share, valuing the company at around $3.3 billion. It had sold 15.2 million shares, raising $425 million. Gemini posted...
Stellantis stops development on electric Ram 1500 pickup
Stellantis stops development on electric Ram 1500 pickup
Sep 12, 2025
DETROIT, Sept 12 (Reuters) - Stellantis ( STLA ) is axing its Ram 1500 electric pickup, citing slow demand for full-size EV trucks, the company said Friday. As demand for full-size battery electric trucks slows in North America, Stellantis ( STLA ) is reassessing its product strategy and will discontinue development of a full-size BEV pickup, a company spokesperson said....
Six Flags Q3 Tracking In Line, Attendance Ahead of Expectations, Truist Says
Six Flags Q3 Tracking In Line, Attendance Ahead of Expectations, Truist Says
Sep 12, 2025
03:29 PM EDT, 09/12/2025 (MT Newswires) -- Six Flags Entertainment ( FUN ) Q3 performance is tracking in line with expectations, offering some reassurance after a weather-impacted Q2 and a major full-year guidance cut, Truist Securities said in a note Friday. The comments followed the company's update that revenue for the nine weeks through Aug. 31 fell 2% year over...
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Sep 12, 2025
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. ( CURX ) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced that Dominari Securities LLC, which acted as the lead underwriter for the Company’s underwritten initial public offering (the “Offering” or the “IPO”), has exercised...
Copyright 2023-2026 - www.financetom.com All Rights Reserved